Helena Podgornik

Jan 15, 2025 | mdpi.com | Katarina Reberšek |Helena Podgornik |Katarina Klinar

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Mar 28, 2024 | nature.com | Annamaria Brioli |Tomasz Sacha |Philipp Ernst |Fausto Castagnetti |Klaus Hirschbühl |Helena Podgornik | +9 more

AbstractBlast phase (BP) of chronic myeloid leukemia (CML) still represents an unmet clinical need with a dismal prognosis. Due to the rarity of the condition and the heterogeneity of the biology and clinical presentation, prospective trials and concise treatment recommendations are lacking.

Mar 22, 2024 | mdpi.com | Helena Podgornik |Gorazd Jakoš

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Nov 1, 2023 | mdpi.com | Martina Fink |Helena Podgornik |Karla Rener

1. IntroductionAging people with hemophilia A (PwHA) with a history of on-demand treatment often require surgical management of hemophilic arthropathy [1,2]. Additionally, increased life expectancy contributes to modern disease comorbidities, most commonly cardiovascular diseases, malignancies, diabetes, obesity, and dementia, all contributing to an increased risk of injuries and need for invasive procedures [1].

Oct 30, 2023 | mdpi.com | Barbara Kramar |Andrej Vovk |Helena Podgornik |Tinkara Pirc Marolt

1. IntroductionAripiprazole (ARI) is an antipsychotic drug for treating mental disorders such as schizophrenia and bipolar disorder. It has fewer side effects than other frequently used second-generation antipsychotics [1]. Nevertheless, the adverse effects include impulsive and compulsive behaviours, such as uncontrollable urges to gamble, overeat, or shop [2].